General Information of the Compound
| Compound ID |
CP0843104
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(5-((1R,3R)-1-(1-ethyl-1H-pyrazol-4-yl)-3-(4-(5-fluoropyridin-2-yl)-1H-imidazol-2-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)-2-oxo-1,3,4-oxadiazol-3(2H)-yl)acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H25FN10O3
|
||||||||||||||||||
| Molecular Weight |
568.573
|
||||||||||||||||||
| Canonical SMILES |
CCn1cc([C@@]2(c3nn(CC(N)=O)c(=O)o3)N[C@@H](c3nc(-c4ccc(F)cn4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C28H25FN10O3/c1-2-38-13-15(10-33-38)28(26-37-39(14-23(30)40)27(41)42-26)24-18(17-5-3-4-6-19(17)34-24)9-21(36-28)25-32-12-22(35-25)20-8-7-16(29)11-31-20/h3-8,10-13,21,34,36H,2,9,14H2,1H3,(H2,30,40)(H,32,35)/t21-,28-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
UDNHVXSMHHOEBX-LYZGTLIUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound